Chemotherapy-Induced Alopecia in Ovarian Cancer: Incidence, Mechanisms, and Impact Across Treatment Regimens

    January 2025 in “ Cancers ”
    Simonetta I. Gaumond, Gabriela E Beraja, Isabella Kamholtz … Joaquín J. Jiménez
    Studysummary This article discusses the importance of optimizing treatment protocols for chemotherapy-induced alopecia and reports no new clinical results; the authors emphasize improving patient outcomes and quality of life.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on mdpi.com →
    Discuss this study in the Community →

    Research cited in this study 10

    1. Prevention and Treatment of Chemotherapy-Induced Alopecia: What Is Available and What Is Coming? Current Oncology · 2023
    2. Hair Loss During and After Breast Cancer Therapy Supportive Care in Cancer · 2023
    3. CDK4/6 Inhibition Mitigates Stem Cell Damage in a Novel Model for Taxane-Induced Alopecia EMBO Molecular Medicine · 2019
    4. Hair Disorders in Patients with Cancer Journal of The American Academy of Dermatology · 2018
    5. The Side Effects of Platinum-Based Chemotherapy Drugs: A Review for Chemists Dalton transactions · 2018
    6. Chemotherapy-Induced Alopecia Management: Clinical Experience and Practical Advice Journal of Cosmetic Dermatology · 2017
    7. Pathobiology of Chemotherapy-Induced Hair Loss The Lancet Oncology · 2013
    8. Chemotherapy-Induced Hair Loss PubMed · 2010
    9. Docetaxel and Oxaliplatin in the Second-Line Treatment of Platinum-Sensitive Recurrent Ovarian Cancer: A Phase II Study Annals of Oncology · 2007
    10. Recurring Chemotherapy-Associated Alopecia Areata: Case Report and Literature Review Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · 2003